Bipartisan Congressional Lawmakers Tell DEA To Allow Psilocybin Treatment For Terminal Patients

Bipartisan members of Congress sent a letter on Tuesday requesting that the Drug Enforcement Administration (DEA) allow terminally ill patients to use psilocybin as an investigational treatment without the fear of federal prosecution. The new letter says DEA has “has failed to abide” by the law. Washington State’s attorney general’s office joined the plaintiffs in support of psilocybin access. The lawmakers’ letter is addressed to DEA Administrator Anne Milgram, who was appointed by President Joe Biden and confirmed by the Senate over the summer. “Urgent action is needed to ensure that people currently suffering terminal illness can elect treatment involving psilocybin,” it says.